{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:34:33Z","timestamp":1786653273166,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Niger Med J"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/0300-1652.149177","type":"journal-article","created":{"date-parts":[[2015,3,2]],"date-time":"2015-03-02T04:12:04Z","timestamp":1425269524000},"page":"74","source":"Crossref","is-referenced-by-count":17,"title":["Coexistence of JAK2 and BCR-ABL mutation in patient with myeloproliferative neoplasm"],"prefix":"10.4103","volume":"56","author":[{"given":"Abdulaziz","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LivingstoneGayus","family":"Dogara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AhmaduAliyu","family":"Babadoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sani","family":"Awwalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AishaIndo","family":"Mamman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0300-1652.149177-1","first-page":"250","volume-title":"Chronic myelogenous leukemia, BCR-ABL1+","author":"Vardiman","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"key-10.4103\/0300-1652.149177-2","first-page":"1","volume-title":"Chronic myeloid leukemia: Practical issues in diagnosis, treatment and follow-up","author":"Buyukasik","year":"2010","journal-title":"Int J Hematol Oncol"},{"key":"key-10.4103\/0300-1652.149177-3","unstructured":"Durosinmi MA. A design Handbook of Haemato-oncology Chemotherapy for Medical Students and Doctors. 3 rd ed. Lagos: AMKRA Books; 2013. p. 15-25."},{"key":"key-10.4103\/0300-1652.149177-4","first-page":"165","volume-title":"ESMO Guidelines Working Group.Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and clinical practice guidelines","author":"Baccarani","year":"2010","journal-title":"Ann Oncol"},{"key":"key-10.4103\/0300-1652.149177-5","first-page":"15","volume-title":"The use of Imatinib mesylate in Nigerians with chronic myeloid leukemia","author":"Durosinmi","year":"2008","journal-title":"Cell Ther Transplant"},{"key":"key-10.4103\/0300-1652.149177-6","first-page":"979","volume-title":"Jak\/STAT pathways in cytokine signaling and myeloproliferative disorders: Approaches for targeted therapies","author":"Jatiani","year":"2010","journal-title":"Genes Cancer"},{"key":"key-10.4103\/0300-1652.149177-7","first-page":"109","volume-title":"JAK2 gene mutation: Impact on pathogenesis, classification, and management of myeloproliferative neoplasms","author":"Latif","year":"2010","journal-title":"Community Oncol"},{"key":"key-10.4103\/0300-1652.149177-8","first-page":"1865","volume-title":"The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera","author":"Lippert","year":"2006","journal-title":"Blood"},{"key":"key-10.4103\/0300-1652.149177-9","first-page":"1528","volume-title":"Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis","author":"Primignani","year":"2006","journal-title":"Hepatology"},{"key":"key-10.4103\/0300-1652.149177-10","first-page":"658","volume-title":"JAK2 -V617F mutation in a patient with Philadelphia- chromosome-positive chronic myeloid leukaemia","author":"Kr\u00e4mer","year":"2007","journal-title":"Lancet Oncol"},{"key":"key-10.4103\/0300-1652.149177-11","first-page":"472","volume-title":"JAK2V617F mutation in chronic myeloid leukemia predicts early disease progression","author":"Pahore","year":"2011","journal-title":"J Coll Physicians Surg Pak"},{"key":"key-10.4103\/0300-1652.149177-12","first-page":"2920","volume-title":"The V617F JAK2 mutation is uncommon in cancers and in myeloid malignancies other than the classic myeloproliferative disorders","author":"Scott","year":"2005","journal-title":"Blood"},{"key":"key-10.4103\/0300-1652.149177-13","first-page":"864","volume-title":"Insight into JAK2-V617F mutation in CML","author":"Bocchia","year":"2008","journal-title":"Lancet Oncol"},{"key":"key-10.4103\/0300-1652.149177-14","first-page":"3370","volume-title":"Brief report JAK2 mutation 1849GT is rare in acute leukemias but can be found in CMML, Philadelphia chromosome negative CML, and megakaryocytic leukemia","author":"Jelinek","year":"2014","journal-title":"Blood"},{"key":"key-10.4103\/0300-1652.149177-15","first-page":"24","volume-title":"Impressive thrombocytosis evolving in a patient with a BCR-ABL positive CML in major molecular response during dasatinib treatment unmasks an additional JAK2V617F","author":"Pastore","year":"2013","journal-title":"Exp Hematol Oncol"},{"key":"key-10.4103\/0300-1652.149177-16","first-page":"1103","volume-title":"Polycythemia associated with the JAK2V617F mutation emerged during treatment of chronic myelogenous leukemia","author":"Inami","year":"2007","journal-title":"Leukaemia"},{"key":"key-10.4103\/0300-1652.149177-17","first-page":"4106","volume-title":"Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation","author":"Hussein","year":"2007","journal-title":"Blood"},{"key":"key-10.4103\/0300-1652.149177-18","first-page":"212","volume-title":"JAK2-V617F mutation and Philadelphia positive chronic myeloid leukemia","author":"Campiotti","year":"2009","journal-title":"Leuk Res"}],"container-title":["Nigerian Medical Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:34:34Z","timestamp":1786649674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0300-1652.149177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"alternative-id":["149177"],"URL":"https:\/\/doi.org\/10.4103\/0300-1652.149177","relation":{},"ISSN":["0300-1652"],"issn-type":[{"value":"0300-1652","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}